hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML [Rituxan Hycela]
RxNorm concept 1927887, branded drug component (sbdc).
- RxCUI
- 1927887
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927887 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 MG/ML [Rituxan Hycela]
Related concepts
- 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] (SBD, constitutes)
- 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] (SBD, constitutes)
- Rituxan Hycela (BN, has ingredient)
- hyaluronidase, human recombinant 2000 UNT/ML (SCDC, tradename of)
- rituximab 120 MG/ML (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1927887 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927887 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1927887. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.